Reported by newKerala.com 5 hours ago.
Italy chooses 'Dogman' for 91st Oscars
↧
↧
Global Sources Fall 2018 trade shows to feature more than 9,000 booths
*Events showcase the latest electronics, lifestyle and fashion products*HONG KONG, Sept. 27, 2018 /PRNewswire/ -- Global Sources will host its 2018 fall trade show series at Hong Kong's AsiaWorld-Expo from October 11 to 30. With more than 9,000 booths, attendees will be able to meet suppliers face to face and see the latest products at four events:
· *Global Sources Electronics
*- Consumer Electronics (October 11 to 14)
- Mobile Electronics (October 18 to 21)
· *Global Sources Lifestyle* (October 27 to 30)
· *Global Sources Fashion* (October 27 to 30)
*World's largest electronics sourcing trade fair*
Global Sources Electronics is the company's flagship show. Comprising two phases, Consumer Electronics and Mobile Electronics, it will feature 7,500 booths of the hottest electronics products from verified suppliers. Exhibitors hail from Greater China, Korea, Germany, Japan, United Kingdom, Italy, Austria, India, Luxembourg, Singapore, Turkey, the Philippines and Bulgaria. The show will also feature product launches, experience and demo zones, conference programs and Startup Launchpad to offer attendees insights into rapidly accelerating technologies in the region.
Consumer Electronics will run from October 11 to 14 with 3,800 booths of home, outdoor, auto electronics, gaming, smart living, components, commercial electronics, and computer and accessories. Mobile Electronics is scheduled to take place from October 18 to 21 and will feature 3,700 booths of mobile devices and accessories, VR/AR, wearables, and mobile speakers and headphones.
Tommy Wong, President of Global Sources Electronics Group, said: "Global Sources' focus on innovative, novelty and high demand products makes our shows must-attend event for buyers from all over the world. We are constantly observing and analyzing industry and consumer trends across every vertical, to adapt our trade-show offerings so that they meet buyers' current and future sourcing needs."
New highlights this October include the "Goldenears Choice" Audio Excellence Award co-organized with the China Audio Industry Association featuring 20 selected products, the launch of the Audio Pavilion, responding to rising demand for audio products with a dedicated sourcing zone of 400 booths, live e-sports performances, Brand Zone and AIOT Park.
Other highlights of the show include Hong Kong's largest collections of auto electronics, gaming, smart living, computer products and personal transporters, as well as Asia's biggest outdoor electronics selection. Pavilions for outdoor electronics, mobile accessories, speakers and headphones, VR & AR, wearables; and smartphones and tablets also rank the largest in Asia. Expanded selections for the October show include gaming, personal transporters, artificial intelligence, AIoT, speakers & headphones and wireless charging. To spotlight high-growth product categories, Analyst's Choice Zone is set to host product launch areas and product demo displays.
*Tech conferences focusing on cutting-edge technology and industry applications*
Global Sources Electronics will host a series of on-site conferences to cover AI, IoT, e-sports & gaming, and VR/AR. Top industry experts will share their views on market trends and industry development.
*The premier sourcing platform for hardware & retail solution startups*
Startup Launchpad is a premier sourcing platform that facilitates global distribution between hardware & retail solution startups and renowned online and offline retailers. Staged at the Mobile Electronics show, it will bring together 300 startups from 21 countries and regions to showcase new innovations covering IoT, wearables, smart home, robotics, VR/AR, supply chain, POS and other high-growth categories.
Startup Launchpad's full-fledged conference program will gather more than 50 thought leaders to share insights on the Future of Retail over 2 days. This Fall sees the addition of an Ecosystem Day, where various players in different markets will inform startups on the resources and funding available in their respective markets. The Startup Launchpad Investment Competition will also return this Fall catering to startups seeking investors and investment strategies. More information is available at http://www.launchpadhk.com.
*Global Sources Lifestyle x Global Sources Fashion *
Global Sources Lifestyle and Global Sources Fashion will be co-located at Asiaworld-Expo from October 27 to 30 to leverage the strengths of both fairs, offering a brand new sourcing experience and providing attendees of each show with an expanded range of complementary sourcing options.
*Lifestyle show features curated and innovative gifts and home products*
Running from October 27 to 30, the new Global Sources Lifestyle show is dedicated to helping buyers find new and creative gifts, premiums and home products from China and across Asia. The show will feature Meet the Millennials, a curation of products that appeal to millennials, and the Lifestyle Live event program, daily live shows on lifestyle product categories hosted by key opinion leaders and influencers. Other show highlights include the Cool Design Awards, Cool Design Gallery, Color Trends Area and New Sourcing Markets Pavilion.
*Largest fashion trade fair in Hong Kong*
Global Sources Fashion is scheduled to run from October 27 to 30 and to showcase a comprehensive range of fashion products, covering apparel, fashion jewelry, underwear and swimwear, bags and luggage, scarves, footwear and fabrics from Greater China, Korea, India, Vietnam, the Philippines, and elsewhere in Asia. The show features the largest collections of bags and luggage, scarves & gloves sports fashion and active lifestyle, underwear and swimwear products in Hong Kong. Other highlights include conference programs, fashion parades, Young and Rising Designers Corners, Trends Forum, Fashion Tech Zone and the 3Rs Sport shoes Design Competition.
*Comprehensive services for online and Amazon sellers*
A range of services will enhance the buying experience of online and Amazon sellers and help them source more efficiently. This includes products from verified suppliers and exhibitors that accept small orders, a conference program featuring online retail experts, as well as the Global Sources Summit. Voted Best Amazon Conference in the 2017 Seller Awards, this three-day conference helps intermediate and advanced Amazon and e-commerce sellers source from Asia.
*Top buyers from 150 countries and territories expected to attend*
Tens of thousands of international top buyers are expected to attend the October 2018 Global Sources trade shows, including executives/purchasing decision makers from Amazon, Best Buy, Burberry, Carrefour, eBay, Gap, H&M, Hasbro, Hewlett-Packard, Intel, Levi's, LG, Li & Fung, Microsoft, Nike, Panasonic, Puma, Qualcomm, Quiksilver, Ralph Lauren, Sears, Skechers, Sony, Swarovski, Target, Tesco and more.
The GlobalSources.com app enables buyers to shortlist exhibitors; find booths, take pictures and then follow exhibitors after the show. Global Sources trade fairs are complemented year-round by 16 industry-specialized websites accessible at GlobalSources.com. Updated daily, each site delivers exclusive content, including Analyst's Choice products, an unbiased selection of new and innovative items.
Buyers can find more information about the Global Sources trade fairs and pre-register to attend at http://www.globalsources.com/exhibitions.
Global Sources news and updates are also available at http://www.corporate.globalsources.com/, Facebook(@GSExpos) and Twitter (@globalsources).
*About Global Sources*
Global Sources is a leading business-to-business media company and a primary facilitator of trade with Greater China.
The company organizes export sourcing shows in Hong Kong every April and October with eight events annually, including the world's largest electronics and mobile electronics shows. Global Sources is also a majority shareholder in Shenzhen International Machinery Manufacturing Industry Exhibition (SIMM) and its related shows - the leading machinery exhibitions in Southern China.
The core business facilitates trade between Asia and the world using English-language media such as trade shows (GlobalSources.com/exhibitions), online marketplaces (GlobalSources.com), magazines, and apps.
More than 1.5 million international buyers, including 94 of the world's top 100 retailers, use these services to obtain product and company information to help them source more profitably from overseas supply markets. These services also provide suppliers with integrated marketing solutions to build corporate image, generate sales leads and win orders from buyers in more than 240 countries and territories.
For over 46 years, Gobal Sources has been serving the B2B industry with a reliable, professional trade platform highly trusted by the Company's buyer and supplier communities.
*Media contact:
*Lierence Li
e-mail: lierenceli@globalsources.com
View original content to download multimedia:http://www.prnewswire.com/news-releases/global-sources-fall-2018-trade-shows-to-feature-more-than-9-000-booths-300719447.html
Related Links :
http://www.corporate.globalsources.com Reported by PR Newswire Asia 4 hours ago.
↧
Harbour City X Jaime Hayon" The Cosmos of Jaime Hayon " - Spanish Talented Artist-Designer Jaime Hayon First Solo Exhibition in Hong Kong
HONG KONG, Sept. 27, 2018 /PRNewswire/ -- Hong Kong Harbour City is proudly presents the new art exhibition of *Jaime Hayon*, one of the most famous Spanish designers, to host his first Hong Kong solo exhibition, *"**The Cosmos of Jaime Hayon" in Harbour City from September 21st to October 17th. *Hayon Cosmos Selection @ Gallery by the Harbour in Harbour CityThe Cosmos of Jaime Hayon @ Harbour City
The exhibition comprises two parts. The first part is named "Archisculptures", transforming Ocean Terminal Forecourt into a huge playground of fantasy! Often employing animals as the theme of his creations, Hayon infuses his imagined animal characters into architecture, resulting in three Archisculptures of weird shapes, bright colours, and dazzling patterns -- the red Cirquepinodome, the yellow Duckodome, and the green Rabbitdoubledome. More amusingly, the Archisculptures are filled with "playful" elements, with periscopes, monkey seesaw, and slide installed respectively.
The second part of the exhibition "Hayon Cosmos Selection", is situated in Gallery by the Harbour. All works are specially created for this exhibition, such as the Faunamask series and the Faunavase series, which are sculptures manifested in ceramic and hand-made in Italy through the workshop of Italo Bosa. There is also the Primitif series, which is presented in wood sculpted by craftsmen Remigio Scarpin from Italy and Josep Jofre from Spain. The works are endowed with value for appreciation and collection.
*"The Cosmos of Jaime Hayon" Art Exhibition
**"Hayon Cosmos Selection"
*Date: 20 / 9 / 2018 - 17 / 10 / 2018
Time: 11am - 10pm
Venue: Gallery by the Harbour, Shop 207, Level 2, Ocean Centre, Harbour City
*"Archisculptures"
*Date: 21 / 9 / 2018 - 17 / 10 / 2018
Time: 10 am - 10pm
Venue: Ocean Terminal Forecourt, Harbour City
*More photos & video:
*https://www.dropbox.com/sh/vkophl9xm66xhs2/AACZb6ak8aOyk6qIZZ41dOPGa?dl=0
*Video on YouTube*: https://youtu.be/-mWUfFtDCbI
*#HarbourCity #HCART #JAIMEHAYON*
*About Jaime Hayon*
Spanish artist-designer Jaime Hayon has won numerous awards, including multiple Elle Decoration International Design Awards. He is included by Wallpaper Magazine in its "Top 100" list, and is recognized as one of the most influential creators of the last decade. In addition, he is lauded as a "visionary" and one of the most creative icons by Time magazine.
Photo - https://photos.prnasia.com/prnh/20180926/2249011-1-a
Photo - https://photos.prnasia.com/prnh/20180926/2249011-1-b
Logo - https://photos.prnasia.com/prnh/20140721/8521404095LOGO
Related Links :
http://www.harbourcity.com.hk Reported by PR Newswire Asia 3 hours ago.
↧
Illegal Ivory Dealers Starting To Use Similar Code Words To Hide Online Sales
Sara Alfino and Dr David Roberts from the Durrell Institute of Conservation and Ecology within the School of Anthropology and Conservation at the University of Kent examined 19 different code words and phrases that have been identified as representing ivory products on sale across four of eBay’s European websites: the UK, Italy, France and Spain.
They found that despite eBay’s ban on ivory sales there were 183 ivory items on sale by 113 sellers during their research window between 18 January and 5 February 2017.
Not only did these sales violate eBay’s trading conditions but some broke regulations under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and EU regulations regarding the sale of ‘unworked’ ivory.
Despite the use of codes to hide sales and the problems this could pose law enforcement agencies working in different languages, the researchers found that the majority of items on offer – around 80% – were grouped around six code words across the four eBay sites monitored.
This suggests the sales of ivory items online between traders is standardising around set code words, even when using different languages, as globalisation and market forces affect their business like any other.
This could help narrow the scope within which law enforcement agencies have to search for the sale of ivory items and allow machine learning tools to be focused on key terms too, helping improve identification of illegal sales.
However, the researchers say further work will be required to monitor sites like Facebook, Twitter, Instagram and Craigslist to see what terms are used. These sites have different ways in which items are presented for sale and therefore it is not known to what extent these code words are not only shared between languages, but also across these online sales platforms.
Nonetheless, if a ‘digital fingerprint’ could be identified for the sale of ivory items or other wildlife trade items that spanned platforms, languages and countries, the global monitoring of wildlife trade could potentially be made easier.
Dr Roberts said: ‘It is clear that identifying illegal online trade in ivory is a challenge for law enforcement agencies. However, the research shows that there are ways in which they can take advantage of market conditions that are forcing traders to standardise on code words to try and find buyers for their goods.’
The paper, Code word usage in the online trade in ivory across four EU member States, has been published in the Oryx-The International Journal of Conservation Fauna & Flora International Reported by Eurasia Review 2 hours ago.
They found that despite eBay’s ban on ivory sales there were 183 ivory items on sale by 113 sellers during their research window between 18 January and 5 February 2017.
Not only did these sales violate eBay’s trading conditions but some broke regulations under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) and EU regulations regarding the sale of ‘unworked’ ivory.
Despite the use of codes to hide sales and the problems this could pose law enforcement agencies working in different languages, the researchers found that the majority of items on offer – around 80% – were grouped around six code words across the four eBay sites monitored.
This suggests the sales of ivory items online between traders is standardising around set code words, even when using different languages, as globalisation and market forces affect their business like any other.
This could help narrow the scope within which law enforcement agencies have to search for the sale of ivory items and allow machine learning tools to be focused on key terms too, helping improve identification of illegal sales.
However, the researchers say further work will be required to monitor sites like Facebook, Twitter, Instagram and Craigslist to see what terms are used. These sites have different ways in which items are presented for sale and therefore it is not known to what extent these code words are not only shared between languages, but also across these online sales platforms.
Nonetheless, if a ‘digital fingerprint’ could be identified for the sale of ivory items or other wildlife trade items that spanned platforms, languages and countries, the global monitoring of wildlife trade could potentially be made easier.
Dr Roberts said: ‘It is clear that identifying illegal online trade in ivory is a challenge for law enforcement agencies. However, the research shows that there are ways in which they can take advantage of market conditions that are forcing traders to standardise on code words to try and find buyers for their goods.’
The paper, Code word usage in the online trade in ivory across four EU member States, has been published in the Oryx-The International Journal of Conservation Fauna & Flora International Reported by Eurasia Review 2 hours ago.
↧
Nicox and Fera Pharmaceuticals to Focus on a Rare Disease Indication for Naproxcinod
*Press Release*
Nicox and Fera Pharmaceuticals to Focus on a Rare Disease Indication for Naproxcinod
*...............................................*
*Nicox and Fera Pharmaceuticals have amended their 2015 agreement for naproxcinod * *Development, under the responsibility of Fera, will now focus on an undisclosed rare disease, which could potentially lead to an orphan drug designation for naproxcinod * *Potential sales-based milestone increased to $40 million if annual sales reach $1 billion * *...............................................*
September 27, 2018 - release at 7:30 am CET
Sophia Antipolis, France
*Nicox SA* (Euronext Paris: FR0013018124, COX), an international ophthalmology company, and Fera Pharmaceuticals, a privately-held, U.S. specialty pharmaceutical company, today announced that they have amended their 2015 license agreement, which granted Fera exclusive rights to develop and commercialize naproxcinod for the U.S. market. The development of naproxcinod will now focus on an undisclosed rare disease, for which Fera expects to seek an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA). Naproxcinod, a Cyclooxygenase-Inhibiting Nitric Oxide (NO)-Donating (CINOD) naproxen, is a non-steroidal anti-inflammatory product candidate originally discovered and developed by Nicox.
*Michele Garufi, Chairman and Chief Executive Officer of Nicox, said,* "We are delighted that Fera intends to take the development of naproxcinod in a new direction, which could potentially lead to an Orphan Drug Designation for naproxcinod in a rare disease. Fera should benefit from the existing chemistry, manufacturing and control data and the extensive nonclinical and clinical safety database for naproxcinod to support a potentially accelerated clinical development program."
*Frank DellaFera, Founder and President of Fera Pharmaceuticals, added* "Naproxcinod has the potential to become an FDA approved drug targeting an unmet medical need in a rare disease. Fera has conducted an extensive review and based on naproxcinod's NO-donating activity, along with its pain-relieving properties, we are looking forward to its further development to potentially provide patients with an important new treatment option."
Nicox and Fera have agreed that the collaboration will now be focused on an undisclosed rare disease. Fera may submit, subject to a successful completion by Fera of a preclinical Proof-of-Concept study, an application for an Orphan Drug Designation for naproxcinod to the FDA. Fera believes that naproxcinod may be able to enter directly into a clinical efficacy study if the Orphan Drug Designation is obtained.
Under the amended agreement, Nicox will now be eligible to potentially receive a single $40 million, sales-based milestone if naproxcinod reaches $1 billion yearly sales (for any indication) in the U. S. This milestone would be payable only once. The royalties remain unchanged at 7% of net sales of naproxcinod in the U.S. Other than as specified in the amendment, Fera remains responsible for all clinical development, manufacturing, regulatory and commercialization activities.
*About Naproxcinod*
* *
Our product candidate naproxcinod is a non-steroidal anti-inflammatory drug (NSAID) that is a nitric oxide (NO)-donating naproxen. The NO-donating mechanism of action makes naproxcinod a cyclooxygenase inhibiting nitric oxide donator (CINOD), a class of drugs that are hoped to produce similar analgesic efficacy to traditional NSAIDs, but with an improved gastrointestinal and cardiovascular side effect profile. A broad clinical package already exists for naproxcinod in osteoarthritis, including three phase 3 studies with over 2,700 patients. Nicox submitted an NDA for naproxcinod for osteoarthritis in 2009 and received a Complete Response Letter in 2010 in which the FDA requested substantial additional long-term safety data.
*About Fera Pharmaceuticals*
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets. For more information visit www.ferapharma.com.
*About Nicox*
Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. By leveraging our proprietary expertise in nitric oxide (NO) donation and other technologies, we are developing an extensive portfolio of novel product candidates that target multiple ophthalmic conditions, including glaucoma. Our portfolio includes three programs in development based on our proprietary NO-donating research platform and on novel and proprietary formulations of well-established molecules that have previously been used in other indications and therapeutic areas as well as future generation stand-alone NO donors in formulation development and testing and other exploratory novel NO-donating compounds targeting ophthalmic conditions including glaucoma and ocular hypertension. In addition, we have two ophthalmology assets that have been approved by the U.S. Food and Drug Administration (FDA); VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024%, exclusively licensed worldwide to Bausch + Lomb, a Bausch Health Companies Inc. company, and commercialized in the U.S. by Bausch + Lomb since December 2017 as well as ZERVIATE(TM) (cetirizine ophthalmic solution), 0.24%, exclusively licensed in the U.S. to Eyevance Pharmaceuticals. Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.
For more information on Nicox, its products or pipeline, please visit: www.nicox.com
*Analyst coverage*
Bryan, Garnier & Co Hugo Solvet Paris, France
Invest Securities Martial Descoutures Paris, France
Gilbert Dupont Jamina El-Bougrini Paris, France
The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports.
*Contacts*
*Nicox*
Gavin Spencer,
Executive Vice President, Chief Business Officer
T +33 (0)4 97 24 53 00
communications@nicox.comInvestors & media
United States
LifeSci Advisors, LLC
Monique Kosse
T +1 212-915-3820
M +1 646-258-5791
monique@lifesciadvisors.com Investors & media
Europe
LifeSci Advisors, LLC
Hans Herklots
T +41 79 598 7149
hherklots@lifesciadvisors.com
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
*Fera Pharmaceuticals*
Scott Florentino, Director, Commercial Development
T +1 (516) 277-1449 ext. 314 Media
France
NewCap
Nicolas Merigeau
T +33 (0)1 44 71 94 98
nicox@newcap.eu
Media
Italy
Argon Healthcare International
Pietro Pierangeli
pietro.pierangeli@argonhealthcare.com
Chiara Tettamanti
chiara.tettamanti@argonhealthcare.com
T +39 02 4951.8300
*Disclaimer*
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.
Risks factors which are likely to have a material effect on Nicox's business are presented in the 4th chapter of the 'Document de référence, rapport financier annuel et rapport de gestion 2017' filed with the French Autorité des Marchés Financiers (AMF) on March 19, 2018, which are available on Nicox's website (www.nicox.com).
*Nicox S.A.*
Drakkar 2
Bât D, 2405 route des Dolines
CS 10313, Sophia Antipolis
06560 Valbonne, France
T +33 (0)4 97 24 53 00
F +33 (0)4 97 24 53 99
*Attachment*
· Press release.pdf Reported by GlobeNewswire 2 hours ago.
Nicox and Fera Pharmaceuticals to Focus on a Rare Disease Indication for Naproxcinod
*...............................................*
*Nicox and Fera Pharmaceuticals have amended their 2015 agreement for naproxcinod * *Development, under the responsibility of Fera, will now focus on an undisclosed rare disease, which could potentially lead to an orphan drug designation for naproxcinod * *Potential sales-based milestone increased to $40 million if annual sales reach $1 billion * *...............................................*
September 27, 2018 - release at 7:30 am CET
Sophia Antipolis, France
*Nicox SA* (Euronext Paris: FR0013018124, COX), an international ophthalmology company, and Fera Pharmaceuticals, a privately-held, U.S. specialty pharmaceutical company, today announced that they have amended their 2015 license agreement, which granted Fera exclusive rights to develop and commercialize naproxcinod for the U.S. market. The development of naproxcinod will now focus on an undisclosed rare disease, for which Fera expects to seek an Orphan Drug Designation from the U.S. Food and Drug Administration (FDA). Naproxcinod, a Cyclooxygenase-Inhibiting Nitric Oxide (NO)-Donating (CINOD) naproxen, is a non-steroidal anti-inflammatory product candidate originally discovered and developed by Nicox.
*Michele Garufi, Chairman and Chief Executive Officer of Nicox, said,* "We are delighted that Fera intends to take the development of naproxcinod in a new direction, which could potentially lead to an Orphan Drug Designation for naproxcinod in a rare disease. Fera should benefit from the existing chemistry, manufacturing and control data and the extensive nonclinical and clinical safety database for naproxcinod to support a potentially accelerated clinical development program."
*Frank DellaFera, Founder and President of Fera Pharmaceuticals, added* "Naproxcinod has the potential to become an FDA approved drug targeting an unmet medical need in a rare disease. Fera has conducted an extensive review and based on naproxcinod's NO-donating activity, along with its pain-relieving properties, we are looking forward to its further development to potentially provide patients with an important new treatment option."
Nicox and Fera have agreed that the collaboration will now be focused on an undisclosed rare disease. Fera may submit, subject to a successful completion by Fera of a preclinical Proof-of-Concept study, an application for an Orphan Drug Designation for naproxcinod to the FDA. Fera believes that naproxcinod may be able to enter directly into a clinical efficacy study if the Orphan Drug Designation is obtained.
Under the amended agreement, Nicox will now be eligible to potentially receive a single $40 million, sales-based milestone if naproxcinod reaches $1 billion yearly sales (for any indication) in the U. S. This milestone would be payable only once. The royalties remain unchanged at 7% of net sales of naproxcinod in the U.S. Other than as specified in the amendment, Fera remains responsible for all clinical development, manufacturing, regulatory and commercialization activities.
*About Naproxcinod*
* *
Our product candidate naproxcinod is a non-steroidal anti-inflammatory drug (NSAID) that is a nitric oxide (NO)-donating naproxen. The NO-donating mechanism of action makes naproxcinod a cyclooxygenase inhibiting nitric oxide donator (CINOD), a class of drugs that are hoped to produce similar analgesic efficacy to traditional NSAIDs, but with an improved gastrointestinal and cardiovascular side effect profile. A broad clinical package already exists for naproxcinod in osteoarthritis, including three phase 3 studies with over 2,700 patients. Nicox submitted an NDA for naproxcinod for osteoarthritis in 2009 and received a Complete Response Letter in 2010 in which the FDA requested substantial additional long-term safety data.
*About Fera Pharmaceuticals*
Fera Pharmaceuticals is a privately held company. The company goal is to realize opportunities via acquisitions, in-licensing, developing and marketing abbreviated new drug applications (ANDAs), new drug applications (NDAs) and 505(b)(2) NDA products. Areas of interest include products that could benefit from lifecycle management with a special focus on niche markets. For more information visit www.ferapharma.com.
*About Nicox*
Nicox S.A. is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. By leveraging our proprietary expertise in nitric oxide (NO) donation and other technologies, we are developing an extensive portfolio of novel product candidates that target multiple ophthalmic conditions, including glaucoma. Our portfolio includes three programs in development based on our proprietary NO-donating research platform and on novel and proprietary formulations of well-established molecules that have previously been used in other indications and therapeutic areas as well as future generation stand-alone NO donors in formulation development and testing and other exploratory novel NO-donating compounds targeting ophthalmic conditions including glaucoma and ocular hypertension. In addition, we have two ophthalmology assets that have been approved by the U.S. Food and Drug Administration (FDA); VYZULTA(TM) (latanoprostene bunod ophthalmic solution), 0.024%, exclusively licensed worldwide to Bausch + Lomb, a Bausch Health Companies Inc. company, and commercialized in the U.S. by Bausch + Lomb since December 2017 as well as ZERVIATE(TM) (cetirizine ophthalmic solution), 0.24%, exclusively licensed in the U.S. to Eyevance Pharmaceuticals. Nicox is headquartered in Sophia Antipolis, France, is listed on Euronext Paris (Compartment B: Mid Caps; Ticker symbol: COX) and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes.
For more information on Nicox, its products or pipeline, please visit: www.nicox.com
*Analyst coverage*
Bryan, Garnier & Co Hugo Solvet Paris, France
Invest Securities Martial Descoutures Paris, France
Gilbert Dupont Jamina El-Bougrini Paris, France
The views expressed by analysts in their coverage of Nicox are those of the author and do not reflect the views of Nicox. Additionally, the information contained in their reports may not be correct or current. Nicox disavows any obligation to correct or to update the information contained in analyst reports.
*Contacts*
*Nicox*
Gavin Spencer,
Executive Vice President, Chief Business Officer
T +33 (0)4 97 24 53 00
communications@nicox.comInvestors & media
United States
LifeSci Advisors, LLC
Monique Kosse
T +1 212-915-3820
M +1 646-258-5791
monique@lifesciadvisors.com Investors & media
Europe
LifeSci Advisors, LLC
Hans Herklots
T +41 79 598 7149
hherklots@lifesciadvisors.com
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
* *
*Fera Pharmaceuticals*
Scott Florentino, Director, Commercial Development
T +1 (516) 277-1449 ext. 314 Media
France
NewCap
Nicolas Merigeau
T +33 (0)1 44 71 94 98
nicox@newcap.eu
Media
Italy
Argon Healthcare International
Pietro Pierangeli
pietro.pierangeli@argonhealthcare.com
Chiara Tettamanti
chiara.tettamanti@argonhealthcare.com
T +39 02 4951.8300
*Disclaimer*
The information contained in this document may be modified without prior notice. This information includes forward-looking statements. Such forward-looking statements are not guarantees of future performance. These statements are based on current expectations or beliefs of the management of Nicox S.A. and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Nicox S.A. and its affiliates, directors, officers, employees, advisers or agents, do not undertake, nor do they have any obligation, to provide updates or to revise any forward-looking statements.
Risks factors which are likely to have a material effect on Nicox's business are presented in the 4th chapter of the 'Document de référence, rapport financier annuel et rapport de gestion 2017' filed with the French Autorité des Marchés Financiers (AMF) on March 19, 2018, which are available on Nicox's website (www.nicox.com).
*Nicox S.A.*
Drakkar 2
Bât D, 2405 route des Dolines
CS 10313, Sophia Antipolis
06560 Valbonne, France
T +33 (0)4 97 24 53 00
F +33 (0)4 97 24 53 99
*Attachment*
· Press release.pdf Reported by GlobeNewswire 2 hours ago.
↧
↧
Italy: Focus on growth – Danske Bank
The big event today will be *Italy *publishing growth, debt and deficit projections for 2019, suggests the research team at Danske Bank.
*Key Quotes*
“We expect 2019 to land somewhere between 2.0-2.4% of GDP, i.e. not violating EU rules. The budget is likely to include some kind of tax reforms and citizen income, but policies are likely to be phased in only gradually or implemented by tweaking some already existing schemes in order to avoid the deficit breaching EU rules.” Reported by FXstreet.com 2 hours ago.
*Key Quotes*
“We expect 2019 to land somewhere between 2.0-2.4% of GDP, i.e. not violating EU rules. The budget is likely to include some kind of tax reforms and citizen income, but policies are likely to be phased in only gradually or implemented by tweaking some already existing schemes in order to avoid the deficit breaching EU rules.” Reported by FXstreet.com 2 hours ago.
↧
Members of Le Pen's Party Say France Should Copy Italy's Tough Migration Rules
Reported by RIA Nov. 2 hours ago.
↧
Breaking News: Italy government may postpone budget meeting - Corriere
The Italian government may postpone the cabinet meeting over the 2019 budget due to new complications in reaching an agreement on the deficit issue, according to Corriere.
** Reported by FXstreet.com 2 hours ago.
** Reported by FXstreet.com 2 hours ago.
↧
Brussels cooks up an Italian budget fudge
Clarity is expected when Giovanni Tria presents Italy’s annual spending plans to parliament
Reported by FT.com 2 hours ago.
↧
↧
EUR/JPY review: Italy's budget worries trigger double top breakdown
· *The EUR has nosedived across the board in the last few minutes, courtesy of Italy's budget worries.*
· *The EUR/JPY has suffered a double top breakdown, could suffer deeper losses if the Italy-Germany yield spread spikes.*
Currently, the EUR/JPY is trading at 131.83, having clocked a session low of 131.67.
The cross has shed more than 60 pips in the last 60 minutes and has peeped below the 200-hour moving average (MA) 132.70, all because of reports stating that Italy's 2019 budget meeting has been postponed, seemingly due to new complications in reaching agreement on the spending plans.
The renewed budget concerns could weigh on the Italian assets. The spread between the 10-year Italian government bond and its German counterpart may spike in the EUR negative manner.
It is worth noting that technical chart is already calling a deeper drop in the EUR/JPY. For instance, the breach of the ascending trendline and the double top breakdown, as seen in the hourly chart, indicates scope for a test of the 200-day MA support, currently lined up at 131.04.
*Hourly chart*
Resistance: 131.90 (double top neckline hurdle), 132.58 (100-hour moving average), 133.13 (Sept. 21 high)
Support: 131.38 (May 14 high), 131.04 (50-day MA), 130.87 (Aug. 30 high) Reported by FXstreet.com 2 hours ago.
· *The EUR/JPY has suffered a double top breakdown, could suffer deeper losses if the Italy-Germany yield spread spikes.*
Currently, the EUR/JPY is trading at 131.83, having clocked a session low of 131.67.
The cross has shed more than 60 pips in the last 60 minutes and has peeped below the 200-hour moving average (MA) 132.70, all because of reports stating that Italy's 2019 budget meeting has been postponed, seemingly due to new complications in reaching agreement on the spending plans.
The renewed budget concerns could weigh on the Italian assets. The spread between the 10-year Italian government bond and its German counterpart may spike in the EUR negative manner.
It is worth noting that technical chart is already calling a deeper drop in the EUR/JPY. For instance, the breach of the ascending trendline and the double top breakdown, as seen in the hourly chart, indicates scope for a test of the 200-day MA support, currently lined up at 131.04.
*Hourly chart*
Resistance: 131.90 (double top neckline hurdle), 132.58 (100-hour moving average), 133.13 (Sept. 21 high)
Support: 131.38 (May 14 high), 131.04 (50-day MA), 130.87 (Aug. 30 high) Reported by FXstreet.com 2 hours ago.
↧
Italian EcoMin Spokesman denies Tria wants to resign
A spokesman from the Italian Economy Ministry denies the rumors that the Finance Minister Tria wants to resign over the budget dispute.
Earlier, it was reported Italy's 2019 budget meeting is delayed. The Italian budget concerns are back in play and pushing the Euro lower across the board.
The EUR/USD pair is back above the 1.17 handle, having reversed a dip to 1.1691 on Italian jitters and broad-based US dollar strength following the Fed’s hawkish tone. Reported by FXstreet.com 2 hours ago.
Earlier, it was reported Italy's 2019 budget meeting is delayed. The Italian budget concerns are back in play and pushing the Euro lower across the board.
The EUR/USD pair is back above the 1.17 handle, having reversed a dip to 1.1691 on Italian jitters and broad-based US dollar strength following the Fed’s hawkish tone. Reported by FXstreet.com 2 hours ago.
↧
EUR/USD comes down to test sub-1.1700, focus on USD, data, Italy
· *The pair is adding to yesterday’s losses and challenges 1.1700.*
· *The greenback stays bid following the rate hike by the Fed.*
· *German flash CPI figures next of relevance in Euroland.*
The European currency is extending the post-Fed leg lower and is now dragging *EUR/USD* to test fresh lows in sub-1.1700 levels.
*EUR/USD now looks to data, Italy*
Spot is extending the downside for the second session in a row on Thursday as market participants continue to digest the somewhat hawkish message from the FOMC meeting.
I addition, uncertainty around the Italian budget appears to have resurfaced, also weighing down on sentiment and lifting Italian yields.
On the USD-side, the US Dollar Index (DXY) manages to get some traction and reclaim the 94.60 area, or daily highs.
Looking ahead, several gauges of sentiment/confidence in Euroland are due later seconded by ECB’s Private Loans and M3 Money Supply, all preceding the more relevant advanced inflation figures in Germany.
Across the pond, Durable Goods Orders, Initial Claims and another revision of Q2 GDP should keep the attention on the buck later in the day.
*EUR/USD levels to watch*
At the moment, the pair is losing 0.29% at 1.1706 finding immediate contention at 1.1691 (low Sep.27) followed by 1.1664 (21-day SMA) and then 1.1526 (low Sep. 10). On the upside, a breakout of 1.1815 (high Sep.24) would target 1.1853 (monthly high Jun.14) en route to 1.1946 (200-day SMA). Reported by FXstreet.com 1 hour ago.
· *The greenback stays bid following the rate hike by the Fed.*
· *German flash CPI figures next of relevance in Euroland.*
The European currency is extending the post-Fed leg lower and is now dragging *EUR/USD* to test fresh lows in sub-1.1700 levels.
*EUR/USD now looks to data, Italy*
Spot is extending the downside for the second session in a row on Thursday as market participants continue to digest the somewhat hawkish message from the FOMC meeting.
I addition, uncertainty around the Italian budget appears to have resurfaced, also weighing down on sentiment and lifting Italian yields.
On the USD-side, the US Dollar Index (DXY) manages to get some traction and reclaim the 94.60 area, or daily highs.
Looking ahead, several gauges of sentiment/confidence in Euroland are due later seconded by ECB’s Private Loans and M3 Money Supply, all preceding the more relevant advanced inflation figures in Germany.
Across the pond, Durable Goods Orders, Initial Claims and another revision of Q2 GDP should keep the attention on the buck later in the day.
*EUR/USD levels to watch*
At the moment, the pair is losing 0.29% at 1.1706 finding immediate contention at 1.1691 (low Sep.27) followed by 1.1664 (21-day SMA) and then 1.1526 (low Sep. 10). On the upside, a breakout of 1.1815 (high Sep.24) would target 1.1853 (monthly high Jun.14) en route to 1.1946 (200-day SMA). Reported by FXstreet.com 1 hour ago.
↧
10 things you need to know in markets today
Good morning! Here is what you need to know on Thursday.*1. **Asian shares held firm on Thursday, outperforming sagging Wall Street shares, and US bond yields fell after the Federal Reserve raised interest rates as expected, sticking to its script of gradual policy tightening.* MSCI's broadest index of Asia-Pacific shares outside Japan rose 0.3%, with South Korea's Kospi hitting three-month highs. European equity futures suggested a weaker opening as investors weigh prospects of additional Fed rate increases.
*2. SoftBank plans to create a new $100 billion fund every two to three years, its CEO Masayoshi Son told Bloomberg Businessweek in an interview published on Thursday.* Son has attracted more than $93 billion to his Vision Fund technology investment vehicle and has flagged his intention to raise further financing.
*3. British Prime Minister Theresa May is losing cabinet support for her plan to revert to a 'no-deal' Brexit if Europe rejects the Chequers proposals, The Times newspaper reported, citing sources.* Cabinet ministers including Brexit secretary Dominic Raab, foreign minister Jeremy Hunt, environment secretary Michael Gove and interior minister Sajid Javid are looking to prevent May from locking Britain into a no-deal Brexit, the report said.
*4. Italy's new government plans to present its first budget targets on Thursday, ending a drawn-out tussle which has pitted the coalition parties against Economy Minister Giovanni Tria.* Reuters reports that the anti-establishment 5-Star Movement and the right-wing League have been pushing Tria, an academic not affiliated to either party, to ramp up the fiscal deficit to finance their promises of tax cuts and higher welfare spending.
*5. Swiss startup SEBA Crypto has raised 100 million Swiss francs ($103 million) to build a bank offering cryptocurrency services to companies and investors while extending traditional banking services to firms in the new industry.* Headed by former UBS managers Guido Buehler as chief executive and Andreas Amschwand as chairman, the group said on Thursday it is seeking a banking and securities dealer license to manage cryptocurrency trading and investments for banks and qualified investors.
*6. Comcast, the victor in the $40 billion auction for Sky, said it had acquired 38% of the British pay-TV group's shares and did not intend to make any further market purchases for now.* Comcast beat Rupert Murdoch's Twenty-First Century Fox in a rare auction held last weekend. Fox said on Wednesday it would sell its 39% stake in Sky to Comcast in a move that helps the US group to complete the deal.
*7. Oil prices rallied up to 1% on Thursday as investors focused on the prospect of tighter markets due to US sanctions against major crude exporter Iran, which are set to be implemented in November.* Front-month Brent crude futures reached $82.17 per barrel.
*8. Payments startup Stripe said on Wednesday it has raised $245 million in funding, better positioning the company to expand to new markets globally and attract bigger customers.* The new funding round values San Francisco-based Stripe, whose products make it easier for companies to accept online payments and bill customers, at $20.25 billion, a dramatic surge from its most recent $9.2 billion valuation in 2016.
*9. Air France KLM's new CEO Benjamin Smith said the French state is prepared to sell its 14% stake in the airline, according to the Financial Times.* Smith said French President Emmanuel Macron was prepared to sell the 14% stake — even though "there are some people in Air France that believe that this is something they can have as an insurance", the FT reported.
*10. **Taiwan said on Thursday its relationship with the Vatican is stable and it would be closely watching developments between China and the Vatican after a landmark deal between the two on the appointment of bishops on the mainland.* The Vatican on Saturday signed an agreement giving it a long-desired say in the appointment of bishops in China, triggering worries among some officials in Taiwan that the Vatican could switch diplomatic recognition to Beijing.
Join the conversation about this story »
NOW WATCH: Ray Dalio says the economy looks like 1937 and a downturn is coming in about two years Reported by Business Insider 27 minutes ago.
↧
↧
Italy's Lega agrees with Five-Star on higher deficit target
Reuters reports that the leader of Italy's right-wing Lega (League) party Matteo Salvini agrees with Five-Star on higher deficit target.
Despite Salvini’s support for higher budget deficit, the fact still remains the Finance Minister Giovanni Tria remains unmoved from his stance of a deficit target of just under 2%. Reported by FXstreet.com 55 minutes ago.
Despite Salvini’s support for higher budget deficit, the fact still remains the Finance Minister Giovanni Tria remains unmoved from his stance of a deficit target of just under 2%. Reported by FXstreet.com 55 minutes ago.
↧
Italy’s Di Maio: ‘Today is a very important day for the new economic forecast'
Italian Deputy Prime Minister Luigi Di Maio is on the wires now, via Reuters, with the key headlines found below.
‘Today is a very important day for the new economic forecast'.
Sees `courageous' budget which will bet on growth.
There is no request for Tria to resign.
He is not aware of any delay of Thursday’s cabinet meeting. Reported by FXstreet.com 41 minutes ago.
‘Today is a very important day for the new economic forecast'.
Sees `courageous' budget which will bet on growth.
There is no request for Tria to resign.
He is not aware of any delay of Thursday’s cabinet meeting. Reported by FXstreet.com 41 minutes ago.
↧
EUR/USD shifts its focus to Italy – Danske Bank
Senior Analyst at Danske Bank Mikael Milhoj noted headlines around the Italian budget should be relevant in the pair’s price action today.
*Key Quotes*
“Yesterday’s FOMC meeting left *EUR/USD* little changed, albeit the initial announcement triggered a spike higher, which was later reversed”.
“Today , focus will turn to the Italian budget proposal. With markets now fully pricing in a budget deficit well below the 3% of GDP threshold, we would have to see a significant negative surprise to see any spill over to FX markets and naturally the EUR in particular”.
“We don’t expect that to be the case and hence today’s release should primarily be important for fixed income markets, in our view”. Reported by FXstreet.com 33 minutes ago.
*Key Quotes*
“Yesterday’s FOMC meeting left *EUR/USD* little changed, albeit the initial announcement triggered a spike higher, which was later reversed”.
“Today , focus will turn to the Italian budget proposal. With markets now fully pricing in a budget deficit well below the 3% of GDP threshold, we would have to see a significant negative surprise to see any spill over to FX markets and naturally the EUR in particular”.
“We don’t expect that to be the case and hence today’s release should primarily be important for fixed income markets, in our view”. Reported by FXstreet.com 33 minutes ago.
↧
Italy's Di Maio unaware of any delay to Thursday's cabinet meeting
Italian Deputy Minister Luigi Di Maio confirmed that a cabinet meeting over budget targets was planned for later on Thursday, dismissing a report in daily Corriere della Sera which said it could be delayed.
Reported by Reuters 10 minutes ago.
↧
↧
Italy economy ministry denies Tria wants to resign over budget tussle
Italy's Economy Minister Giovanni Tria does not plan to resign over a budget disagreement with the ruling parties, a spokeswoman for the ministry said on Thursday, dismissing a report in daily La Stampa which said he "was ready to leave".
Reported by Reuters 10 minutes ago.
↧
Italy hikes deficit, defying EU, as economy minister caves in
By Giuseppe Fonte and Angelo Amante ROME (Reuters) - Italy's government on Thursday targeted the budget deficit at 2.4 percent of gross domestic product for the next three years, defying Brussels and marking a victory for party chiefs over economy minister Giovanni Tria, an unaffiliated technocrat. Tria had initially wanted a deficit set as low as 1.6 percent next year, hoping to respect European Union demands that Italy progressively cut the fiscal gap to rein in its high debt
Reported by Firstpost 2 hours ago.
↧
Instant View: Reaction to Italian budget targets
Italy's government has targeted a budget deficit of 2.4 percent of gross domestic product for the next three years, defying Brussels and marking a victory for ruling-party chiefs over economy minister Giovanni Tria.
Reported by Reuters 2 hours ago.
↧
More Pages to Explore .....
